PHIO PHARMACEUTICALS CORP (PHIO)
US71880W4024 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.83M | -11.48M | -13.29M | -8.79M | -8.91M | |||
| Depreciation Amortization | 56.00K | 70.00K | 80.00K | 70.00K | 70.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -536.00K | -1.26M | 990.00K | -330.00K | -210.00K | |||
| Interest Paid | N/A | N/A | 10.00K | 10.00K | 0.00 | |||
| Other non cash items | 557.00K | 540.00K | 360.00K | 250.00K | 410.00K | |||
| OPERATING CASH FLOW | -10.75M | -12.13M | -11.86M | -8.80M | -8.65M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.00K | -120.00K | -50.00K | -20.00K | -70.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -5.00K | -120.00K | -50.00K | -20.00K | -70.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 200.00K | -10.00K | |||
| Stock Issued/Repurchased | 7.45M | 0.00 | 21.72M | 15.94M | 780.00K | |||
| Other Financing Activity | -37.00K | -30.00K | 0.00 | -20.00K | 0.00 | |||
| FINANCING CASH FLOW | 7.41M | -30.00K | 21.72M | 16.13M | 770.00K | |||
| CHANGE IN CASH | -3.34M | -12.28M | 9.81M | 7.31M | -7.95M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.75M | -12.13M | -11.86M | -8.80M | -8.65M | |||
| Capital Expenditure | -5.00K | -120.00K | -50.00K | -20.00K | -70.00K | |||
| FREE CASH FLOW | -10.75M | -12.25M | -11.91M | -8.82M | -8.72M | |||
All data in USD